# Catabolic Mechanism of 17β-Estradiol in Rhodococcus erythropolis KB1: Insights from Metabolomics, Genomics, and Transcriptomics

**Authors:** Jinglin Ma, Yan Zhuang, Huiting Guan, Zhenjun Zhang, Ning Zhu, Changze Han, Yonggang Wang, Jixiang Chen

PMC · DOI: 10.4014/jmb.2601.01017 · 2026-02-26

## TL;DR

This study identifies how Rhodococcus erythropolis KB1 breaks down the hormone 17β-estradiol using multiple pathways and gene activity, offering potential for environmental cleanup.

## Contribution

The study reveals five putative degradation pathways and key gene responses in a bacterial strain for efficient 17β-estradiol catabolism.

## Key findings

- Rhodococcus erythropolis KB1 degraded 96.75% of 50 mg/L 17β-estradiol in nine days.
- Five putative degradation pathways were identified, including 4,5- and 9,10-seco pathways.
- Transcriptomic analysis showed significant induction of SDR and cyp genes involved in E2 degradation.

## Abstract

The release and prolonged retention of steroid hormones pose significant risks to both human health and the environment. Research on efficient-degrading bacteria at higher concentrations and their degradation pathways, genes, and enzymes is limited. In this study, Rhodococcus erythropolis KB1 efficiently degraded 96.75% of 50 mg/L 17β-estradiol (E2) within nine days. Including the 4,5- and 9,10-seco pathways, five putative degradation pathways were identified based on the analysis of metabolic intermediates and products using high-performance liquid chromatography–quadrupole–time-of-flight–mass spectrometry (HPLC-Q-TOF-MS). Under the proposed aerobic pathways, E2 undergoes hydroxylation or cleavage at ring A or B. The resultant products are subsequently converted into a common steroid metabolite, 3aα-H-4α(3′-propanoate)-7aβ-methylhexahydro-1,5-indanedione (HIP), via β-oxidation. HIP is further degraded through a central pathway and ultimately assimilated into the tricarboxylic acid (TCA) cycle. Whole-genome sequencing predicted a steroid degradation-related gene cluster on contig NZ_CP050127.1. Transcriptomic analysis demonstrated that the expression of the short-chain dehydrogenase (SDR) gene and three cyp genes in this gene cluster were significantly induced by E2. Additionally, the global response of E2 in strain KB1 was analyzed using transcriptome analysis. Various genes involved ATP-binding cassette (ABC) transport system, electron transfer and energetic metabolism, and stress response—were significantly increased in mRNA levels in response to strain KB1 that can use E2 as the single carbon source. These findings highlight strain KB1 as a promising candidate for E2 biodegradation, offer novel insights into the microbial mechanisms of E2 catabolism, and establish a theoretical basis for future applications.

## Linked entities

- **Genes:** CAVIN2 (caveolae associated protein 2) [NCBI Gene 8436], PPIG (peptidylprolyl isomerase G) [NCBI Gene 9360]
- **Chemicals:** 17β-estradiol (PubChem CID 154274)

## Full-text entities

- **Genes:** TRNG (tRNA-Gly) [NCBI Gene 4563] {aka MTTG}, DLD (dihydrolipoamide dehydrogenase) [NCBI Gene 1738] {aka DLDD, DLDH, E3, GCSL, LAD, OGDC-E3}, FDXR (ferredoxin reductase) [NCBI Gene 2232] {aka ADR, ADXR, ANOA, MMDS9B}, OGDH (oxoglutarate dehydrogenase) [NCBI Gene 4967] {aka AKGDH, E1k, E1o, HsOGDH, KGD1, OGDC}, CYTB (cytochrome b) [NCBI Gene 4519] {aka MTCYB}, PDP1 (pyruvate dehydrogenase phosphatase catalytic subunit 1) [NCBI Gene 54704] {aka PDH, PDP, PDPC, PDPC 1, PPM2A, PPM2C}, HSD17B6 (hydroxysteroid 17-beta dehydrogenase 6) [NCBI Gene 8630] {aka HSE, RODH, SDR9C6}, MPG (N-methylpurine DNA glycosylase) [NCBI Gene 4350] {aka AAG, ADPG, APNG, CRA36.1, MDG, PIG11}, CYP2B6 (cytochrome P450 family 2 subfamily B member 6) [NCBI Gene 1555] {aka CPB6, CYP2B, CYP2B7, CYPIIB6, EFVM, IIB1}, LBX1-AS1 (LBX1 antisense RNA 1) [NCBI Gene 399806] {aka MUSE}, FOLR1P1 (folate receptor 1 pseudogene 1) [NCBI Gene 390221] {aka FOLR1P, KB-1}
- **Diseases:** cancer (MESH:D009369), MFS (MESH:D008382)
- **Chemicals:** 16-OH-E2 (-), bisphenol (MESH:C543008), ethyl acetate (MESH:C007650), benzoate (MESH:D001565), glycerol (MESH:D005990), amino acid (MESH:D000596), NADPH (MESH:D009249), caprolactam (MESH:D002209), ZnCl2 (MESH:C016837), toluene (MESH:D014050), mineral (MESH:D008903), oil (MESH:D009821), succinyl-CoA (MESH:C012046), aminobenzoate (MESH:D062365), phenylalanine (MESH:D010649), flavin adenine dinucleotide (MESH:D005182), Steroid (MESH:D013256), carbon dioxide (MESH:D002245), ATP (MESH:D000255), AMP (MESH:D000249), (NH4)2SO4 (MESH:D000645), dodecane (MESH:C007548), octadecane (MESH:C022883), 4-OH-E1 (MESH:C026418), GC (MESH:C057580), NADH (MESH:D009243), methanol (MESH:D000432), polytetrafluoroethylene (MESH:D011138), oxygen (MESH:D010100), ammonia (MESH:D000641), nitrogen (MESH:D009584), androstenedione (MESH:D000735), 17beta-Estradiol (MESH:D004958), xylene (MESH:D014992), monobactam (MESH:D008997), TCA (MESH:D014233), carbon (MESH:D002244), ADP (MESH:D000244), acetonitrile (MESH:C032159), styrene (MESH:D020058), benzene (MESH:D001554), water (MESH:D014867), Estrone (MESH:D004970), acetyl-CoA (MESH:D000105), atrazine (MESH:D001280), naphthalene (MESH:C031721), CaCl2 (MESH:D002122), polycyclic aromatic hydrocarbon (MESH:D011084), cholesterol (MESH:D002784)
- **Species:** Sphingomonas sp. (species) [taxon 28214], Rhodococcus ruber Chol-4 (strain) [taxon 1240349], Rhodococcus sp. (in: high G+C Gram-positive bacteria) (species) [taxon 1831], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Sphingomonas sp. KC8 (species) [taxon 1030157], Homo sapiens (human, species) [taxon 9606], Caenibius tardaugens (species) [taxon 169176], Rhodococcus aetherivorans (species) [taxon 191292], Microbacterium (genus) [taxon 33882], Pseudomonas putida SJTE-1 (strain) [taxon 1193499], Acinetobacter radioresistens (species) [taxon 40216], Caenibius tardaugens NBRC 16725 (strain) [taxon 1219035], Comamonas testosteroni (species) [taxon 285], Ochrobactrum sp. (species) [taxon 42190], Novosphingobium sp. (species) [taxon 1874826], Lysinibacillus (genus) [taxon 400634]
- **Cell lines:** ES2-1 — Homo sapiens (Human), Embryonic stem cell (CVCL_C769), SKP — Homo sapiens (Human), Chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_TL39), -4 — Homo sapiens (Human), Ataxia telangiectasia syndrome, Finite cell line (CVCL_F083), JX021450.1 — Homo sapiens (Human), Juxtaglomerular cell tumor, Cancer cell line (CVCL_M085)

## Figures

12 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12975502/full.md

---
Source: https://tomesphere.com/paper/PMC12975502